DAWN HANNA: Open Payments
NPI 1063454825 · SAINT FRANCISVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 63 payments from 14 companies in 2025. Trend: 2023 $913 · 2024 $775 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $266 |
| ABBVIE INC. | 21 | $190 |
| GlaxoSmithKline, LLC. | 8 | $145 |
| PFIZER INC. | 5 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $54 |
| Lilly USA, LLC | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Organon LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: VRAYLAR, Wegovy, TRELEGY ELLIPTA, ELIQUIS, VOQUEZNA, Rybelsus, Ozempic, Auvelity.
Industry payments across LA — which companies pay providers there.
